Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3892)
All Articles published online
|
Jun 21, 2006 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Karidis NP, Kouraklis G, Theocharis SE. Platelet-activating factor in liver injury: A relational scope. World J Gastroenterol 2006; 12(23): 3695-3706 [PMID: 16773686 DOI: 10.3748/wjg.v12.i23.3695] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3695.htm |
| Number | Citing Articles |
| 1 |
Haralabos C. Karantonis, Georgios Gribilas, Ioannis Stamoulis, Constantinos Giaginis, Chara Spiliopoulou, Gregorios Kouraklis, Constantinos Demopoulos, Stamatios E. Theocharis. Platelet-Activating Factor Involvement in Thioacetamide-Induced Experimental Liver Fibrosis and Cirrhosis. Digestive Diseases and Sciences 2010; 55(2): 276 doi: 10.1007/s10620-009-0745-0
|
| 2 |
Hiromi Funayama, Ling Huang, Tadasu Sato, Yuko Ohtaki, Yoshinobu Asada, Takashi Yokochi, Haruhiko Takada, Shunji Sugawara, Yasuo Endo. Pharmacological characterization of anaphylaxis-like shock responses induced in mice by mannan and lipopolysaccharide. International Immunopharmacology 2009; 9(13-14): 1518 doi: 10.1016/j.intimp.2009.09.006
|
| 3 |
Chi Li, Yang-Jie Ru, Quan-Yue Lin, Guang-Chun Gao, Yu-Die Yang, Xiao-Qin Zhang, Jin-Lai Gao, Shi-Hui Liu, Chu-Wei Zheng, Lin Wang, Ya-Xin Zheng, Ji-Ming Wu. Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study. Fitoterapia 2022; 162: 105290 doi: 10.1016/j.fitote.2022.105290
|
| 4 |
Paraskevi Detopoulou, Tzortzis Nomikos, Elizabeth Fragopoulou, Smaragdi Antonopoulou. Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers. Current Vascular Pharmacology 2021; 19(6): 663 doi: 10.2174/1570161119666210628125239
|
| 5 |
Limin Feng, Ying Zhao, Guofang Feng, Yu Chen. Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-105
|
| 6 |
Eleonora Stanca, Gaetano Serviddio, Francesco Bellanti, Gianluigi Vendemiale, Luisa Siculella, Anna Maria Giudetti. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: Potential antiinflammatory effect of silybin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(12): 2019 doi: 10.1016/j.bbadis.2013.07.005
|
| 7 |
Alessandro Federico, Marcello Dallio, Carmelina Loguercio. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules 2017; 22(2): 191 doi: 10.3390/molecules22020191
|
| 8 |
Pamela Czajka, Adam Przybyłkowski, Anna Nowak, Marek Postula, Marta Wolska, Dagmara Mirowska-Guzel, Anna Czlonkowska, Ceren Eyileten. Antiplatelet drugs and liver fibrosis. Platelets 2022; 33(2): 219 doi: 10.1080/09537104.2021.1883574
|
| 9 |
Debra L. Laskin, Vasanthi R. Sunil, Carol R. Gardner, Jeffrey D. Laskin. Macrophages and Tissue Injury: Agents of Defense or Destruction?. Annual Review of Pharmacology and Toxicology 2011; 51(1): 267 doi: 10.1146/annurev.pharmtox.010909.105812
|
| 10 |
D.L. Laskin, C.R. Gardner, J.D. Laskin. Comprehensive Toxicology. 2010; : 133 doi: 10.1016/B978-0-08-046884-6.00607-2
|
| 11 |
Gang Liu, Alan W. Baird, Marie J. Parsons, Kening Fan, David A. Skerrett‐Byrne, Prema M. Nair, Samwel Makanyengo, Jinbiao Chen, Rachel Neal, Bridie J. Goggins, Hock Tay, Andrea Mathe, Wai S. Soh, Kyra Minahan, Phil M. Hansbro, Brett Nixon, Geoffrey W. McCaughan, Gerald Holtmann, Sean P. Colgan, Simon Keely. Platelet activating factor receptor acts to limit colitis‐induced liver inflammation. The FASEB Journal 2020; 34(6): 7718 doi: 10.1096/fj.201901779R
|
| 12 |
Erika Ramos-Tovar, Pablo Muriel. Dietary Interventions in Liver Disease. 2019; : 101 doi: 10.1016/B978-0-12-814466-4.00009-4
|
| 13 |
Alexandros Tsoupras, Ronan Lordan, Ioannis Zabetakis. Inflammation, not Cholesterol, Is a Cause of Chronic Disease. Nutrients 2018; 10(5): 604 doi: 10.3390/nu10050604
|